Thank you, Mr. Chair.
To the witnesses, thank you so much for coming.
I'll pick up on the database. A national database is critical in understanding the extent of the problem. It allows us to evaluate various clinical interventions and it can be used to target education and training initiatives. We now understand that this database is not going to be available until March 2012. Is there anything you can suggest in the meantime to track data?
I will also ask about a national strategy. If you could write your wish list for this committee, what is that national strategy, and what are your key recommendations for it, please?